BSE filing, NSE: SHAREINDIA. Summary written from the filing by ALFA Finder's alert engine.
Share India Securities Ltd: key numbers
- Share price
- ₹182.92
- Market cap
- ₹3,992 Cr
- Revenue (annual)
- ₹1,470 Cr
- Net profit (annual)
- ₹323.5 Cr
- P/E (TTM)
- 10.7×Sector 19.5×
- Promoter holding
- 48.62%+0.00% QoQ
- FII holding
- 1.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Share India Securities Ltd
All →Share India Securities Employee Stock Options
Share India Securities granted 3,80,500 employee stock options under its ESOS-II scheme. Each option converts to one equity share at a Rs.2 exercise price.
- Execution
- Exercisable from vesting, expiring not later than 1 year after the last vesting date
Share India Securities Capital Structure Change
Share India Securities allotted 44,02,000 equity shares under its Silverleaf Capital amalgamation scheme. It also granted 3,80,500 employee stock options under ESOS-II.
Share India Securities Board Meeting Date
Share India Securities will hold a board meeting on November 06, 2026 to consider an amalgamation scheme with Ace Alpha Tech. Trading window stays closed pending disclosures.
Share India Securities Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹3,795 Mn (+11.3% YoY), PAT ₹1,025 Mn (+10.0%); H1 PAT +32.3%. Strategy: monetise existing client base via MTF, wealth, NBFC and tech.
Share India Securities Results Update
Share India Securities reported Q2 FY27 income of ₹3,795 Mn, up 11.3% YoY. PAT rose 10% to ₹1,025 Mn, and a ₹0.40 interim dividend was declared.
Share India Securities Management Change
Share India Securities appointed Krishan Singh Barguzar as Non-Executive Independent Director for 36 months, effective 30 October 2026. He is a former SBI Chief General Manager.
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr